Overall rank by patents
#22,127
of 50,000 tracked assignees
USPTO PatentsView assignee record - 12 granted patents across 9 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61J (CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES ).
The verdict
According to USPTO PatentsView, Adienne ranks #22,127 of 50,000 tracked US assignees by granted-patent volume, with 12 patents across 9 technology areas.
USPTO PatentsView assignee plate
Corpus R22127 · Foreign Corporation #22,127 · 12 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Ablerex Electronics Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Allen-vanguard · near
31 score
Petram · near
31 score
Savage Arms · near
31 score
Adienne Pharma &biot… · this assignee
31 score
Vanderbilt Chemicals · near
31 score
3D Lighting Innovati… · lowest
7 score
What this shows Adienne's Innovation Score is 30.8/100 (top 64% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Adienne Pharma &biotech Sa is a focused PatentsView assignee: 9 CPC subclasses with 83.3% of grants classified under A61J (CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES ). Peak complete grant year is 2019 (5 grants) versus a trough of 1 in 2021. By volume, Adienne sits between Ablerex Electronics Co., Ltd. and AF Chemicals, Llc.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ABLEREX ELECTRONICS CO., LTD.
12 patents
ABU DHABI POLYMERS CO. LTD. (BOROUGE) L.L.C.
12 patents
ABU DHABI POLYMERS COMPANY LIMITED (BOROUGE)
12 patents
ACCUSONUS, INC.
12 patents
ADTRAN NETWORKS SE
12 patents
ADURO BIOTECH HOLDINGS, EUROPE B.V.
12 patents
ADVANCED INTERNATIONAL MULTITECH CO., LTD.
12 patents
AF CHEMICALS, LLC
12 patents
ADIENNE PHARMA &BIOTECH SA
12 patents
What this shows Adienne holds 12 patents at rank #22,119, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #22,119 in granted patent volume.
Other assignees with the most granted patents in Adienne's primary technology class.
Two PlainPatent-derived peer sets for Adienne, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (31 here).
Adienne's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
31 Top 64% higher than 36% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 2 | 16.7% |
| 2019 | 5 | 41.7% |
| 2021 | 1 | 8.3% |
| 2022 | 1 | 8.3% |
| 2023 | 1 | 8.3% |
| 2024 | 1 | 8.3% |
| 2025partial year | 1 | 8.3% |
Top 9 of 9 technology areas
Overall rank by patents
#22,127
of 50,000 tracked assignees
30.8 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.